Similar Articles
691 Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
692 Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review
693 Multidisciplinary approach for multifocal, bilobar hepatocellular carcinoma: A case report and literature review
694 Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
695 Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
696 Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma
697 Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma
698 Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
699 One in five hepatocellular carcinoma patients in the United States are Hispanic while less than 40% were eligible for liver transplantation
700 Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA